⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 6, 2019Science Translational MedicineOpen Access

Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus

Rita G. Kansal Noah Richardson Indira Neeli Saleem Khawaja Damian Chamberlain Marium Ghani Qurat-ul-ain Ghani Louisa Balázs Šárka Beranová-Giorgianni Francesco Giorgianni James N. Kochenderfer Tony N. Marion Lorraine M. Albritton Marko Radic

View Full Paper

Ask AI

Bookmark

Share

Abstract

CD19-targeted CAR T cells show sustained CD19 + B cell depletion and profound therapeutic benefit in ameliorating disease in mouse models of lupus.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kansal et al. (2019) studied this question.

synapsesocial.com/papers/698e2a1ab0728b1abf3b5750 https://doi.org/10.1126/scitranslmed.aav1648

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Dengue virus controlled human challenge reveals that preexisting immunity shapes viral replication and broadly protective responsesScience Translational Medicine · 2026
2Brain-sensing synNotch–CAR T cells enable precise targeting and clearance of diffuse midline glioma in multiple preclinical modelsScience Translational Medicine · 2026
3Acute kidney injury as a systemic diseaseScience Translational Medicine · 2026
4Keratinocyte-derived CHI3L2 reprograms phospholipid metabolism to promote skin inflammation in psoriasisScience Translational Medicine · 2026
5T cell–mediated depletion of intratumoral regulatory T cells using a CCR8xCD3 T cell–engaging bispecific antibody (TCB) promotes antitumor immunity in preclinical mouse modelsScience Translational Medicine · 2026

MIF-CD74 orchestrates synovial macrophage metabolic-inflammatory reprogramming by ENO2 interaction to drive osteoarthritis pathogenesisScience Translational Medicine · 2026
B cell subsets are associated with durable responses in distinct cancer types after immune checkpoint inhibitionScience Translational Medicine · 2026
The kinase inhibitor dabrafenib halts progression of cerebral cavernous malformations in a BRAF-independent mannerScience Translational Medicine · 2026
Targeting ZIP12-mediated Zn 2+ signaling as a treatment for pulmonary hypertensionScience Translational Medicine · 2026
A 5 + 1 polyene scaffold that selectively recognizes ergosterol’s conjugated diene uncouples antifungal potency from host toxicityScience Translational Medicine · 2026

More from Science Translational Medicine

More from National Cancer Institute

More from Center for Cancer Research

More from University of Tennessee Health Science Center